GENE, an esteemed journal published by Elsevier, serves as a vital resource for researchers and professionals in the fields of genetics and medicine. With an ISSN of 0378-1119 and an E-ISSN of 1879-0038, this scholarly journal has been at the forefront of genetic research since its inception in 1976 and is set to continue until 2025. Situated in the Netherlands, GENE is recognized for its significant contributions, reflected in its Q2 ranking in both Genetics and Miscellaneous Medicine categories for 2023. This positioning within the Scopus rankings demonstrates its impact and relevance in a competitive field, where it holds the rank of #129 out of 347 in Genetics, placing it within the 62nd percentile. Although it does not offer open access options, GENE provides invaluable insight into contemporary genetic research, thereby fostering academic discussions and advancements. Researchers, professionals, and students alike will find GENE an essential platform for disseminating knowledge and exploring innovative developments in genetics and associated sciences.

Virchows Archiv, published by Springer, is an esteemed journal dedicated to the fields of Medicine and Pathology, featuring high-quality research from various domains including Cell Biology and Molecular Biology. With its inception dating back to 1947, Virchows Archiv has been a pivotal platform for advancing the understanding of pathological and forensic medicine. As evidenced by its impressive Scopus rank, placing it within the top 15% of journals in Pathology and Forensic Medicine, it continues to maintain a strong presence with a Q1 classification in its category as of 2023. Although it does not offer Open Access options, the journal remains critical for researchers and professionals seeking to publish and access pioneering findings that can impact clinical practices and the academic community. The journal’s rigorous peer-review process ensures that only the highest quality research is disseminated, making it an essential resource for those engaged in the ever-evolving fields of health and biological sciences.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Oral & Maxillofacial Pathology Journal is a prominent peer-reviewed publication dedicated to advancing the field of oral and maxillofacial pathology. Published by the KAIRALI SOCIETY OF ORAL & MAXILLOFACIAL PATHOLOGISTS, this journal aims to provide a platform for sharing innovative research, clinical practices, and new techniques related to the diagnosis and management of oral diseases. With a commitment to open access, it ensures that valuable knowledge reaches a global audience of researchers, dental professionals, and students alike. Although specific impact metrics such as the HIndex and Scopus ranking are not listed, the journal is regarded as an essential resource for those involved in the oral health community. It plays a crucial role in fostering collaboration and disseminating cutting-edge advancements that can enhance patient care and clinical outcomes in oral pathology. For professionals looking to stay ahead in this dynamic field, Oral & Maxillofacial Pathology Journal serves as an indispensable tool for both foundational learning and advanced research.

Welcome to the International Journal of Biological Markers, a distinguished publication under SAGE Publications Ltd that has been a vital resource in the fields of Cancer Research, Clinical Biochemistry, Oncology, and Pathology and Forensic Medicine since its inception in 1986. With a commitment to disseminating high-quality research, the journal enjoys a robust impact highlighted by its Q2 and Q3 rankings across multiple categories in 2023, as evidenced by its Scopus rankings placing it in respectable percentiles. Based in Italy, this journal serves a global audience of researchers, clinicians, and students eager to keep abreast of the latest discoveries involving biological markers and their applications in medicine. Emphasizing rigorous peer review and scholarly integrity, the International Journal of Biological Markers plays a crucial role in advancing knowledge that can significantly impact clinical practices and enhance patient care.

HISTOLOGY AND HISTOPATHOLOGY, published by F HERNANDEZ, is an esteemed academic journal dedicated to advancing the fields of histology and pathology. With its ISSN 0213-3911 and E-ISSN 1699-5848, this journal has been a crucial resource for researchers and professionals since its inception in 1986. The journal enjoys a strong reputation, evidenced by its Q2 category rankings in both Histology and Pathology & Forensic Medicine as of 2023, positioning it within the top tier of scholarly publications. With Scopus rankings placing it at Rank #74/208 in Medicine - Pathology and Forensic Medicine and Rank #31/62 in Medicine - Histology, it proves to be an essential platform for disseminating significant research findings and innovations. Although the journal is not open access, it is committed to providing high-quality, peer-reviewed articles that cater to the needs of its academic community. With a focus on fostering a deeper understanding of tissue structure and disease mechanisms, HISTOLOGY AND HISTOPATHOLOGY serves as an indispensable resource for students, researchers, and practitioners alike, facilitating the exchange of knowledge and pioneering research in these vital areas of study.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.

Diagnostic Pathology is a prominent open-access journal published by BMC, dedicated to advancing the field of pathology by providing a platform for high-quality research findings since its inception in 2006. Based in the United Kingdom, the journal covers a broad spectrum of topics within the realms of histology, pathology, and forensic medicine, facilitating discussions that are crucial for both clinical and laboratory settings. With an impressive impact factor that places it in the Q2 category across multiple categories including Histology and Miscellaneous Medicine, it ranks favorably in Scopus with notable positions in the 71st and 55th percentiles for Pathology and Histology respectively. As a valuable resource for researchers, professionals, and students alike, Diagnostic Pathology promotes the dissemination of cutting-edge studies and findings, thereby contributing significantly to the evolving landscape of medical science. The journal’s commitment to open access enhances its accessibility, ensuring that valuable research is freely available to a global audience.